These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 13380825)

  • 1. [Management of diabetes with a peroral sulfonamide derivative, BZ 55; preliminary experience].
    AARSETH S
    Tidsskr Nor Laegeforen; 1956 Sep; 76(18):641-6. PubMed ID: 13380825
    [No Abstract]   [Full Text] [Related]  

  • 2. [Case of very severe allergic reaction in peroral management of diabetes mellitus with a sulfonyl urea derivative, N1-sulfanilyl-N2-n-butylcarbamide].
    FELLER J; KUPPER HJ
    Medizinische; 1956 Nov; 1(46):1641-5. PubMed ID: 13386742
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of a hypoglycemic sulfonamide derivative (BZ 55) on the effectiveness of insulin in diabetics].
    BARTELHEIMER H; MARING H
    Klin Wochenschr; 1956 Oct; 34(37-38):1011-6. PubMed ID: 13377627
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral treatment of diabetes mellitus with the sulfonamide BZ-55.
    HERNBERG CA
    Acta Endocrinol (Copenh); 1956 Nov; 23(3):281-8. PubMed ID: 13381391
    [No Abstract]   [Full Text] [Related]  

  • 5. [BZ 55 treatment; preliminary experience].
    GLEDITSCH E
    Tidsskr Nor Laegeforen; 1956 Sep; 76(18):647-8. PubMed ID: 13380826
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences with peroral administration of antidiabetic drug BZ-55 (invenol)].
    BRESGEN C
    Med Klin; 1956 Jul; 51(29):1224-7. PubMed ID: 13358484
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of ten cases of diabetes with oral hypoglycemic sulfonamide BZ 55 or nadisan].
    FERNANDEZ BASABE E; GALAN J; OLIVER A; OLIVER-PASCUAL E; PURAS E
    Rev Esp Enferm Apar Dig Nutr; 1956; 15(2):478-88. PubMed ID: 13370980
    [No Abstract]   [Full Text] [Related]  

  • 8. [Severe hypoglycemic reactions during peroral treatment of diabetes with N1-sulfanilyl-n-2-n-butylcarbamid (BZ 55)].
    BENDFELDT E; OTTO H
    Munch Med Wochenschr; 1956 Aug; 98(35):1136-7. PubMed ID: 13369451
    [No Abstract]   [Full Text] [Related]  

  • 9. [Contra-regulatory diabetes, and its peroral treatment; preliminary report].
    BOTELHO LS; COLACO M; DA CRUZ MF; FERNANDEZ M
    J Med (Oporto); 1956 Jul; 30(705):637-43. PubMed ID: 13366537
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bz 55 diabetes therapy; preliminary results in a series of 65 cases].
    ARVIDSSON SO; EDLEN A; SODERLUND J; STRANDQUIST S
    Sven Lakartidn; 1956 Jul; 53(28):1788-94. PubMed ID: 13360673
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with carbutamide (BZ-55); a progress report.
    CAMERINI-DAVALOS R; MARBLE A; ROOT HF
    Diabetes; 1957; 6(1):74-7; discussion, 85-90. PubMed ID: 13397432
    [No Abstract]   [Full Text] [Related]  

  • 12. [The antidiabetic action of BZ 55 in clinical experience].
    BELTRAMETTI L; ZAMPORI O
    G Clin Med; 1956 Sep; 37(9):1249-64. PubMed ID: 13384741
    [No Abstract]   [Full Text] [Related]  

  • 13. [Peroral treatment of diabetes. I].
    KUHLMANN F
    Med Klin; 1956 Nov; 51(44):1878-81. PubMed ID: 13386825
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of BZ 55].
    BAQUET R
    Maroc Med; 1956 Jul; 35(374):731-3. PubMed ID: 13368691
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and pharmacological effects of substance BZ-55 in diabetes; (p-aminophenylsulfonyl butylcarbamide).
    ANDERSON RC; KIRTLEY WR; RIDOLFO AS; ROOT MA
    Diabetes; 1956; 5(5):351-7. PubMed ID: 13365474
    [No Abstract]   [Full Text] [Related]  

  • 16. [Introduction of new peroral hypoglycemic drugs for the ambulant treatment of diabetes mellitus].
    STRATMANN FW
    Medizinische; 1956 Sep; 24(36):1253-7. PubMed ID: 13377930
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanism of action of BZ 55 in human diabetes].
    BASTENIE PA; CONARD V; DE MEUTTER R; FRANCKSON JR
    Bull Mem Soc Med Hop Paris; 1956; 72(26):799-806. PubMed ID: 13383374
    [No Abstract]   [Full Text] [Related]  

  • 18. [New observations regarding the use of BZ 55 in the treatment of diabetes].
    Baquet R
    Maroc Med; 1957 Mar; 36(382):271-3. PubMed ID: 13429949
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diabetes. II. Indications and results of BZ 55 therapy in 25 cases].
    ROUZAUD C
    Concours Med; 1956 Aug; 78(31):3475-80. PubMed ID: 13365234
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences in diabetes therapy with hypoglycemic sulfonamide compounds].
    BREDNOW W; JORKE D
    Munch Med Wochenschr; 1957 Jan; 99(4):101-5. PubMed ID: 13407645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.